Building the SynBio community in the Czech Republic from the
bottom up: You get what you give

J 2022

Building the SynBio community in the Czech Republic from the bottom up: You get what you give

JURAČKA, Stanislav; Barbora HRNČÍŘOVÁ; Barbora BURÝŠKOVÁ; Daniel GEORGIEV; Pavel DVOŘÁK et al.

Základní údaje

Originální název

Building the SynBio community in the Czech Republic from the bottom up: You get what you give

Autoři

JURAČKA, Stanislav; Barbora HRNČÍŘOVÁ ; Barbora BURÝŠKOVÁ; Daniel GEORGIEV a Pavel DVOŘÁK

Vydání

Biotechnology Notes, Elsevier B.V. 2022, 2665-9069

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

20801 Environmental biotechnology

Stát vydavatele

Nizozemské království

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14310/22:00127501

Organizační jednotka

Přírodovědecká fakulta

DOI

https://doi.org/10.1016/j.biotno.2022.11.002

EID Scopus

2-s2.0-85164099991

Klíčová slova anglicky

Synthetic biology; Czech Republic; EU13 countries; Community; iGEM; Research landscape; Biotechnology and bioengineering; Public perception

Štítky

14314010, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 19. 12. 2022 08:41, Mgr. Marie Novosadová Šípková, DiS.

Anotace

V originále

Given its highly innovative character and potential socioeconomic impact, Synthetic Biology is often ranked among prominent research areas and national research priorities in developed countries. The global evolution of this field is proceeding by leaps and bounds but its development at the level of individual states varies widely. Despite their current satisfactory economic status, the majority of 13, mostly post-communist, countries that entered the European Union family in and after 2004 (EU13) have long overlooked the blossoming of Synthetic Biology. Their prioritized lines of research have been directed elsewhere or “Synthetic Biology” did not become a widely accepted term to encompass their bioengineering and biotechnology domains. The Czech Republic is not an exception. The local SynBio mycelium already exists but is mainly built bottom-up through the activities of several academic labs, iGEM teams, and spin-off companies. In this article, we tell their individual stories and summarize the prerequisites that allowed their emergence in the Czech academic and business environment. In addition, we provide the reader with a brief overview of laboratories, research hubs, and companies that perform biotechnology and bioengineering-oriented research and that may be included in a notional “shadow SynBio community” but have not yet adopted Synthetic Biology as a unifying term for their ventures. We also map the current hindrances for a broader expansion of Synthetic Biology in the Czech Republic and suggest possible steps that should lead to the maturity of this fascinating research field in our country.

Návaznosti

GA22-10845S, projekt VaV

Název: Studium role polyhydroxyalkanoátů u bakterie Schlegelella thermodepolymerans – slibného bakteriálního kandidáta pro biotechnologie nové generace (Akronym: PHAST)

Investor: Grantová agentura ČR, Studium role polyhydroxyalkanoátů u bakterie Schlegelella thermodepolymerans – slibného bakteriálního kandidáta pro biotechnologie nové generace

MUNI/J/0003/2021, interní kód MU

Název: A new generation bacterial platform for lignocellulose biotechnology (Akronym: NEWGEN)

Investor: Masarykova univerzita, A new generation bacterial platform for lignocellulose biotechnology, MASH JUNIOR - MUNI Award In Science and Humanities JUNIOR

Citovat

JURAČKA, Stanislav; Barbora HRNČÍŘOVÁ; Barbora BURÝŠKOVÁ; Daniel GEORGIEV a Pavel DVOŘÁK. Building the SynBio community in the Czech Republic from the bottom up: You get what you give. Biotechnology Notes. Elsevier B.V., 2022, roč. 3, December, s. 124-134. ISSN 2665-9069. Dostupné z: https://doi.org/10.1016/j.biotno.2022.11.002.

@article{2240841,
   author = {Juračka, Stanislav and Hrnčířová, Barbora and Burýšková, Barbora and Georgiev, Daniel and Dvořák, Pavel},
   article_number = {December},
   doi = {https://doi.org/10.1016/j.biotno.2022.11.002},
   keywords = {Synthetic biology; Czech Republic; EU13 countries; Community; iGEM; Research landscape; Biotechnology and bioengineering; Public perception},
   language = {eng},
   issn = {2665-9069},
   journal = {Biotechnology Notes},
   title = {Building the SynBio community in the Czech Republic from the bottom up: You get what you give},
   url = {https://www.sciencedirect.com/science/article/pii/S2665906922000137},
   volume = {3},
   year = {2022}
}

TY  - JOUR
ID  - 2240841
AU  - Juračka, Stanislav - Hrnčířová, Barbora - Burýšková, Barbora - Georgiev, Daniel - Dvořák, Pavel
PY  - 2022
TI  - Building the SynBio community in the Czech Republic from the bottom up: You get what you give
JF  - Biotechnology Notes
VL  - 3
IS  - December
SP  - 124-134
EP  - 124-134
PB  - Elsevier B.V.
SN  - 26659069
KW  - Synthetic biology
KW  - Czech Republic
KW  - EU13 countries
KW  - Community
KW  - iGEM
KW  - Research landscape
KW  - Biotechnology and bioengineering
KW  - Public perception
UR  - https://www.sciencedirect.com/science/article/pii/S2665906922000137
N2  - Given its highly innovative character and potential socioeconomic impact, Synthetic Biology is often ranked among prominent research areas and national research priorities in developed countries. The global evolution of this field is proceeding by leaps and bounds but its development at the level of individual states varies widely. Despite their current satisfactory economic status, the majority of 13, mostly post-communist, countries that entered the European Union family in and after 2004 (EU13) have long overlooked the blossoming of Synthetic Biology. Their prioritized lines of research have been directed elsewhere or “Synthetic Biology” did not become a widely accepted term to encompass their bioengineering and biotechnology domains. The Czech Republic is not an exception. The local SynBio mycelium already exists but is mainly built bottom-up through the activities of several academic labs, iGEM teams, and spin-off companies. In this article, we tell their individual stories and summarize the prerequisites that allowed their emergence in the Czech academic and business environment. In addition, we provide the reader with a brief overview of laboratories, research hubs, and companies that perform biotechnology and bioengineering-oriented research and that may be included in a notional “shadow SynBio community” but have not yet adopted Synthetic Biology as a unifying term for their ventures. We also map the current hindrances for a broader expansion of Synthetic Biology in the Czech Republic and suggest possible steps that should lead to the maturity of this fascinating research field in our country.
ER  -

JURAČKA, Stanislav; Barbora HRNČÍŘOVÁ; Barbora BURÝŠKOVÁ; Daniel GEORGIEV a Pavel DVOŘÁK. Building the SynBio community in the Czech Republic from the bottom up: You get what you give. \textit{Biotechnology Notes}. Elsevier B.V., 2022, roč.~3, December, s.~124-134. ISSN~2665-9069. Dostupné z: https://doi.org/10.1016/j.biotno.2022.11.002.

Přehled o publikaci